A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 303-307

  Saito, Yuri ^a   Shibayama, Hirohiko ^a   Tanaka, Hirokazu ^a   Tanimura, Akira ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anamorsin; Cell proliferation; CyclinD1; P38MAPK; PKC

Indexed keywords

ANAMORSIN; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C THETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; DOWN REGULATION; EMBRYO; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; FIBROBLASTS; IMIDAZOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PYRIDINES; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 79651471412     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.033     Document Type: Article

References (16)

1. Shibayama H., Takai E., Matsumura I., Kouno M., Morii E., Kitamuara Y., Takeda J., Kanakura Y. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J. Exp. Med. 2004, 199:581-592.
2. Mantel C., Guo Y., Lee M.R., Kim M.-K., Han M.-K., Shibayama H., Fukuda S., Yoder M.C., Pelus L.M., Kim K.-S., Broxmeyer H.E. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotypic instability. Blood 2007, 109:4518-4527.
3. Li X., Wu K., Fan D. CIAPIN1 as a therapeutic target in cancer. Ther. Targets. 2010, 14:1-8.
4. Li X., Pan Y., Fan R., Jin H., Han S., Liu J., Wu K., Fan D. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 2008, 29:1587-1593.
5. Hao Z., Li X., Qiao T., Du R., Hong L., Fan D. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol. Ther. 2006, 5:261-266.
6. Li X., Hong L., Zhao Y., Jin H., Fan R., Du R., Xia L., Luo G., Fan D. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem. Biochem. Cell Biol. 2007, 85:741-750.
7. Shizusawa T., Shibayama H., Murata S., Saitoh Y., Sugimoto Y., Matsumura I., Ogawa H., Sugiyama H., Fukuhara S., Hino M., Kanamara A., Yamauchi A., Aozasa K., Kanakura Y. The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients. Leuk. Lymphoma 2008, 49:113-121.
8. He L., Wang H., Jin H., Guo C., Xie H., Yan K., Li X., Shen Q., Qiao T., Chen G., Chai N., Zhao L., Dong Q., Zheng Y., Liu J., Fan D. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett. 2009, 276:88-94.
9. Sakai H., Yamamoto M., Chiba Y., Misawa M. Some different effect of PKC inhibitors on the acetylcholine, and endothelin-1 induced contractions of rat bronchial smooth muscle. Eur. J. Pharmacol. 2009, 618:58-62.
10. Pearson G., Robinson F., Gibson T.B., Xu B.-e., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:152-183.
11. Coulthard L.R., White D.E., Jones D.L., McDermott M.F., Burchill S.A. p38MAPK: stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 2009, 15:369-379.
12. Page K., Li J., Hershenson M.B. p38 MAP kinase negatively regulates cyclinD1 expression in airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L955-L964.
13. Lee M.R., Duan W., Tan S.-L. Protein kinase C isozymes as potential therapeutic targets in immune disorders. Expert Opin. Ther. Targets 2008, 12:535-552.
14. Rosse C., Linch M., Kermorgant S., Cameron A.J.M., Boeckeler K., Parker P.J. PKC and the control of localized signal dynamics. Nat. Rev. Mol. Cell Biol. 2010, 11:103-112.
15. Christoffersen T., Guren T.K., Spindler K.-L.G., Dahl O., Lonning P.E., Gjertsen B.T. Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. Eur. J. Pharmacol. 2009, 625:6-22.
16. Ciavarella S., Milano A., Dammacco F., Silvestris F. Targeted therapies in cancer. Biodrugs 2010, 24:77-88.